One Pager as on July 31, 2023
Balanced portfolio with growth focus | |
Security selection through robust process frameworks | |
Suitable for planning long term goals | |
Data as on July 31, 2023
Sector | MMAHF | CRISIL Hybrid 35+65 Aggressive Index |
Financial Services | 24.43% | 32.65% |
Capital Goods | 7.93% | 2.97% |
Information Technology | 7.64% | 10.60% |
Oil Gas & Consumable Fuels | 5.39% | 10.17% |
Automobile And Auto Components | 4.38% | 6.40% |
Data as on July 31, 2023
Security | % to Net Assets |
HDFC Bank Limited | 6.31% |
ICICI Bank Limited | 6.27% |
Reliance Industries Limited | 4.46% |
State Bank of India | 4.13% |
Infosys Limited | 3.66% |
Tata Consultancy Services Limited | 2.50% |
Axis Bank Limited | 2.18% |
Larsen & Toubro Limited | 2.14% |
UltraTech Cement Limited | 1.93% |
Bharti Airtel Limited | 1.78% |
Total | 35.37% |
Security | % to Net Assets |
7.26% GOI (MD 06/02/2033) (SOV) | 4.38% |
7.06% GOI (MD 10/04/2028) (SOV) | 2.85% |
7.38% GOI (MD 20/06/2027) (SOV) | 2.49% |
7.26% GOI (MD 22/08/2032) (SOV) | 1.95% |
Small Industries Dev Bank of India (CD) | 1.90% |
Total | 13.56%% |
Annualised Portfolio YTM*1^ | 7.36%3 |
Macaulay Duration^ | 3.16 years3 |
Modified Duration^ | 3.043 |
Residual Maturity^ | 4.09 years3 |
Portfolio Turnover Ratio (Last 1 year) | 0.64 |
Standard Deviation | 11.32% |
Beta2 | 1.10 |
Sharpe Ratio# | 1.26 |
Jenson’s Alpha | 0.2214 |
As on (Date) | July 31, 2023 |
*In case of semi annual YTM, it will be annualised ^For debt component
#Risk-free rate assumed to be 6.60% (MIBOR as on 31-07-23) - Source: www.mmda.org
1Yield to maturity should not be construed as minimum return offered by the Scheme; 2Beta is calculated
on the basis of average monthly rolling returns as of last day of the month since inception till July 31, 2023 and annualized 3Calculated on amount invested in debt securities (including accrued interest),
deployment of funds in TREPS and Reverse Repo and net receivable / payable.
Calculated for the period since inception till July 31, 2023. | Data Source: ICRA Analytics, Bloomberg |
Data as on July 31, 2023 | N.A.: Net Assets
Fresh Additions | Complete Exits |
Security | Security |
Biocon Limited | Abbott India Limited |
GAIL (India) Limited | Dr. Reddy's Laboratories Limited |
HCL Technologies Limited | Endurance Technologies Limited |
Mahindra & Mahindra Limited | Exide Industries Limited |
Natco Pharma Limited | LTIMindtree Limited |
Union Bank of India | Mahindra & Mahindra Limited |
Note: The companies/stock(s) referred above are only for the purpose of disclosure of significant portfolio changes during the month and should not be construed as recommendation to buy/sell/ hold. The fund manager may or may not choose to hold these companies/stocks, from time to time. Investors are requested to consult their financial, tax and other advisors before taking any investment decision(s). Data as on July 31, 2023
^Benchmark ^^Additional Benchmark. CAGR – Compounded Annual Growth Rate. Inception/Allotment date: 19-Jul-19.
Past performance may or may not be sustained in future and should not be used as a basis of comparison with other investments. Since inception returns of the scheme is calculated on face value of Rs. 10 invested at inception. The performance details provided above are of Growth Option under Regular Plan. Different Plans i.e Regular Plan and Direct Plan under the scheme has different expense structure. *Based on standard investment of Rs. 10,000 made at the beginning of the relevant period. Ms. Fatema Pacha is managing this scheme since October 16, 2020. Mr. Manish Lodha is managing this fund since December 21, 2020.
^Benchmark ^^Additional Benchmark. CAGR – Compounded Annual Growth Rate. Inception/Allotment date: 19-Jul-19.
Past performance may or may not be sustained in future and should not be used as a basis of comparison with other investments. Returns greater than 1 year period are compounded annualized. For SIP returns, monthly investment of equal amounts invested on the 1st business day of every month has been considered. CAGR Returns (%) are computed after accounting for the cash flow by using the XIRR method (investment internal rate of return).
^Benchmark CAGR – Compounded Annual Growth Rate. $Dedicated Fund Manager for Overseas Investments.
Past performance may or may not be sustained in future and should not be used as a basis of comparison with other investments.
The performance details provided above are of Growth Option under Regular Plan Different Plans i.e Regular Plan and Direct Plan under the scheme has different expense structure. Mr. Rahul Pal manages 10 schemes, Ms. Fatema Pacha manages 8 schemes and Mr. Manish Lodha manages 10 schemes each of Mahindra Manulife Mutual Fund. The performance data for the schemes which have not completed one year has not been provided.
Note: ##Pursuant to change in Fund Management Responsibilities, the scheme shall be co-managed by Mr. Manish Lodha, Mr. Renjith Sivaram, Mr. Rahul Pal and Mr. Kush Sonigara (Dedicated Fund Manager for Overseas Investments)effective July 3, 2023.
This product is suitable for investors who are seeking*:
• Long term capital appreciation and
generation of income;
• Investment in equity and equity
related instruments and debt and
money market instruments.
*Investors should consult their financial advisers if in doubt about whether the product is suitable for them.